Investors Are Watching: EMC Corporation (NYSE:EMC), Cliffs Natural Resources Inc. (NYSE:CLF), Sanderson Farms, Inc. (NASDAQ:SAFM), Albany Molecular Research Inc. (NASDAQ:AMRI), PAA

On Oct 28, Spanning Cloud Apps, Inc., the most trusted provider of data backup and recovery for cloud applications, today announced that it has been acquired by EMC Corporation (NYSE:EMC). The company will continue to operate under the Spanning® Cloud Apps brand in Austin, Texas and will be the foundation of EMC’s “born-in-the-cloud” data protection strategy in its Core Technologies Division. Terms of the acquisition … Continue reading Investors Are Watching: EMC Corporation (NYSE:EMC), Cliffs Natural Resources Inc. (NYSE:CLF), Sanderson Farms, Inc. (NASDAQ:SAFM), Albany Molecular Research Inc. (NASDAQ:AMRI), PAA

Chris Lewis11/1011/10

Investors Are Watching : Banco Bradesco (NYSE:BBD), Qlik Technologies (NASDAQ:QLIK), Albany Molecular Research Inc. (NASDAQ:AMRI), CNB Financial Corp. (NASDAQ:CCNE), Credicorp (NYSE:BAP)

Banco Bradesco S.A. (NYSE:BBD) Brazil’s second-largest private-sector lender, beat second-quarter profit estimates by a large margin on Wednesday after managing to incorporate the impact of higher borrowing costs into earnings. Banco Bradesco S.A. (NYSE:BBD)’s stock on 30 July traded at beginning with a price of $15.69and when day-trade ended the stock finally decreased -1.02% to end at $15.50. Banco Bradesco S.A. (NYSE:BBD)’s showed weekly performance … Continue reading Investors Are Watching : Banco Bradesco (NYSE:BBD), Qlik Technologies (NASDAQ:QLIK), Albany Molecular Research Inc. (NASDAQ:AMRI), CNB Financial Corp. (NASDAQ:CCNE), Credicorp (NYSE:BAP)

Chris Lewis07/3108/12

FB Nasdaq FB Facebook

Healthcares Week’s 20% Gainers: Chimerix Inc. (NASDAQ:CMRX), TESARO (NASDAQ:TSRO), Albany Molecular Research (NASDAQ:AMRI), Vanda Pharmaceuticals (NASDAQ:VNDA)

Chimerix Inc. (NASDAQ:CMRX) shares hit a new high on Thursday with the biotechnology firm continuing to get a boost from its decision to increase a test program for a virus-fighting drug so it can try to save a cruelly ill 7-year-old boy. Chimerix Inc. (NASDAQ:CMRX) stock performance was 2.80% in last session and finished the day at $27.14. Traded volume was 477,612.00 shares in the … Continue reading Healthcares Week’s 20% Gainers: Chimerix Inc. (NASDAQ:CMRX), TESARO (NASDAQ:TSRO), Albany Molecular Research (NASDAQ:AMRI), Vanda Pharmaceuticals (NASDAQ:VNDA)

John Bellich03/1703/17

Biotech Overbought Socks: Xencor Inc. (NASDAQ:XNCR), Albany Molecular Research (NASDAQ:AMRI), Oncothyreon (NASDAQ:ONTY), OXiGENE Inc. (NASDAQ:OXGN)

Xencor, Inc. (NASDAQ:XNCR), a clinical-stage biopharmaceutical company developing engineered monoclonal antibodies for the treatment of autoimmune diseases, asthma and allergic diseases, and cancer, announced that it will release fourth quarter and full year 2013 financial results after market close on Wednesday, March 19, 2014. Xencor Inc. (NASDAQ:XNCR) stock performance was -1.58% in last session and finished the day at $13.68. Traded volume was 99,904.00 shares … Continue reading Biotech Overbought Socks: Xencor Inc. (NASDAQ:XNCR), Albany Molecular Research (NASDAQ:AMRI), Oncothyreon (NASDAQ:ONTY), OXiGENE Inc. (NASDAQ:OXGN)

Jayne Crisman03/1403/14

Biotech Unusual Volume: OXiGENE Inc (NASDAQ:OXGN), TESARO Inc (NASDAQ:TSRO), Discovery Laboratories (NASDAQ:DSCO), Albany Molecular Research (NASDAQ:AMRI)

OXiGENE Inc (NASDAQ:OXGN) on Mar. 11 announced positive results from a randomized Phase 2 clinical trial evaluating Avastin(R) (bevacizumab) with or without ZYBRESTAT(R) (fosbretabulin; CA4P) to treat patients with recurrent ovarian cancer. The study, known as Gynecologic Oncology Group protocol 186I, met its primary endpoint of a statistically significant increase in progression-free survival (p-value less than 0.05; hazard ratio 0.685) for the combination as compared … Continue reading Biotech Unusual Volume: OXiGENE Inc (NASDAQ:OXGN), TESARO Inc (NASDAQ:TSRO), Discovery Laboratories (NASDAQ:DSCO), Albany Molecular Research (NASDAQ:AMRI)

Jason Knox03/1403/14

FB Nasdaq FB Facebook

Biotech Stocks Touching New Highs: Clovis Oncology (NASDAQ:CLVS), Vanda Pharmaceuticals (NASDAQ:VNDA), Insys Therapeutics (NASDAQ:INSY), Albany Molecular Research (NASDAQ:AMRI)

Clovis Oncology Inc. reported a fourth quarter loss of $0.92 per share after the bell Thursday, compared to the loss of $0.81 per share last year. Clovis Oncology Inc. (NASDAQ:CLVS) stock performance was 1.58% in last session and finished the day at $79.62. Traded volume was 0.00 shares in the last session and the average volume of the stock remained 589,825.00 shares. The beta of … Continue reading Biotech Stocks Touching New Highs: Clovis Oncology (NASDAQ:CLVS), Vanda Pharmaceuticals (NASDAQ:VNDA), Insys Therapeutics (NASDAQ:INSY), Albany Molecular Research (NASDAQ:AMRI)

Jason Knox03/0303/03